COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-79
Condition: COVID-19 Interventions: Drug: Apixaban 2.5 MG; Drug: Apixaban 5MG; Drug: Aspirin; Drug: Placebo Sponsors: Frank C Sciurba; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials